• 进京通行证限次数!70.9万辆本地化使用外埠号牌车或将受影响 2019-02-15
  • 电视剧《半生缘》“命运版”海报出炉 2019-02-15
  • 湖南官员办公室纵火身亡 因投资亏损与他人纠纷 2019-02-05
  • 河北省对中央环保督察“回头看”问题整改进行部署 强化标本兼治 防止整改问题反弹 2019-02-04
  • 全面深化改革开放 海南如何成新标杆(政策解读) 2019-02-04
  • 过端午到沁县 观龙舟竞赛 2019-01-29
  • 好坏大家判 事事有人管 2019-01-29
  • 麻建军:认真做好每件事 2019-01-29
  • 西藏:雪域高原唱响教育歌 2019-01-22
  • 国家开发银行获第十二届人民企业社会责任奖年度企业奖 2019-01-22
  • 文瀛公园第二届百合花展 2019-01-20
  • 一笔“农”墨绘山川——重庆市万州区国家农业公园速写 2019-01-02
  • 李劭凯:今天我们为什么读《孟子》 2019-01-02
  • 诺基亚刘海屏新机曝光 4月27日线上开卖 2018-12-30
  • 苏州大学研究生支教团网上众筹资助留守儿童 2018-12-27
  • Skip to main content
    Adjuvants vétérinaires prêts à l'emploi

    新疆25选七走势图: MONTANIDE? Range

    新疆福彩25选七 www.nwxy.net Ready-to-use veterinary adjuvants

    Selecting the right adjuvant is one of the keys to success of a veterinary vaccine in the field. Safety and efficacy balance must be taken into account, as well as the animal species and its sensitivity, the antigen (inactivated or live), its type (viral, bacterial, parasite) and its nature (crude extract, purified, recombinant, peptide, DNA), the desired immune response kinetics (short or long-term) and its profile (humoral or cellular), and the administration route (injection, mucosal, mass vaccination). Since the 70's, SEPPIC has been combining expertise and service to develop MONTANIDE? adjuvants adapted to the veterinary needs.

    MONTANIDE? range

    To meet vaccine developers' needs and to improve efficacy and stability of veterinary vaccines, SEPPIC has developed a wide range of ready-to-use adjuvants based on 3?technologies: emulsions, micro-emulsions and polymers.

    These veterinary adjuvants are manufactured under International Pharmaceutical Excipient Council (IPEC) manufacturing guidelines in SEPPIC manufacturing sites of Castres (France) and Qing Pu (China).

    MONTANIDE? safety and regulatory status

    Based on toxicological tests and field experience, MONTANIDE? adjuvants are considered as safe for veterinary applications such as vaccines.

    MONTANIDE? adjuvants and their components have been approved by the Committee for Veterinary Medical Products (CVMP) for use in immunological products. Their components are either included in the Allowed Substances table of the Annex to European Council Regulation (EU) No?37/2010 as substances needing no further Maximum Residue Limits (MRL) studies, or considered as not falling within the scope of Regulation (EC) No?470/2009 when used in a veterinary product.

    The properties of the antigenic medium are crucial for both vaccine efficacy and safety. Each team developing a vaccine has to study the safety and efficacy profile of the formula under development according to local market acceptance criteria.

    Services around MONTANIDE?

    Expertise and know how
    Bibliographic searches, vaccination protocols, efficacy screening on mice

    Formulation studies
    Selection among pharmaceutical technologies (emulsion, polymer, solid form, etc.)

    Selection of samples
    Adapted to the model of the customer for vaccine stability and performance

    Scale-up assistance
    From the laboratory to small and large scale industrial production

    Customized formulation
    For specific antigens, delivery systems, new concepts

    Training & worshops
    Vaccine formulation, laboratory and pilot processes, quality control of adjuvants and vaccines

    Regulatory affairs support
    For vaccine registration, customs, etc.

  • 进京通行证限次数!70.9万辆本地化使用外埠号牌车或将受影响 2019-02-15
  • 电视剧《半生缘》“命运版”海报出炉 2019-02-15
  • 湖南官员办公室纵火身亡 因投资亏损与他人纠纷 2019-02-05
  • 河北省对中央环保督察“回头看”问题整改进行部署 强化标本兼治 防止整改问题反弹 2019-02-04
  • 全面深化改革开放 海南如何成新标杆(政策解读) 2019-02-04
  • 过端午到沁县 观龙舟竞赛 2019-01-29
  • 好坏大家判 事事有人管 2019-01-29
  • 麻建军:认真做好每件事 2019-01-29
  • 西藏:雪域高原唱响教育歌 2019-01-22
  • 国家开发银行获第十二届人民企业社会责任奖年度企业奖 2019-01-22
  • 文瀛公园第二届百合花展 2019-01-20
  • 一笔“农”墨绘山川——重庆市万州区国家农业公园速写 2019-01-02
  • 李劭凯:今天我们为什么读《孟子》 2019-01-02
  • 诺基亚刘海屏新机曝光 4月27日线上开卖 2018-12-30
  • 苏州大学研究生支教团网上众筹资助留守儿童 2018-12-27